Johannes R. Björk

University Medical Center Groningen — Netherlands

Biochemistry, Genetics and Molecular Biology · Life Sciences

20h-index3.4kcitations62works25.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gut microbiota and health(32), Clostridium difficile and Clostridium perfringens research(8), Marine Sponges and Natural Products(8), Diet and metabolism studies(8), Renal Transplantation Outcomes and Treatments(7)

Publications62 total

Pharmacomicrobiomics: The Role of the Gut Microbiome in Immunomodulation and Cancer Therapy
Gastroenterology·2025· 11 cited
Plasma Versus Whole Blood Tacrolimus Concentrations and Health-Related Quality of Life in Kidney Transplant Recipients
Pharmaceutics·2025· 1 citedOpen Access
Gut microbiome dysbiosis is not associated with portal vein thrombosis in patients with end-stage liver disease: a cross-sectional study
Journal of Thrombosis and Haemostasis·2025· 4 citedOpen Access
Probing the functional significance of wild animal microbiomes using omics data
Functional Ecology·2024· 19 citedOpen Access
Inflammatory Bowel Disease in patients with Primary Sclerosing Cholangitis: a distinct form of colitis
2024Open Access
Multiple indicators of gut dysbiosis predict all-cause and cause-specific mortality in solid organ transplant recipients
Gut·2024· 12 citedOpen Access
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome
Cell·2024· 136 citedOpen Access
The gut microbiome in end-stage lung disease and lung transplantation
mSystems·2024· 7 citedOpen Access
34 SINGLE-CELL RNA SEQUENCING IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE: A DISTINCT FORM OF COLITIS
Gastroenterology·2024
Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease
Nature Communications·2024· 56 citedOpen Access
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Nature Medicine·2024· 109 citedOpen Access
Probing the functional significance of wild animal microbiomes using omics data
2024· 5 citedOpen Access
P119 Single-cell RNA sequencing in Inflammatory Bowel Disease in patients with Primary Sclerosing Cholangitis: a distinct form of colitis
Journal of Crohn s and Colitis·2024Open Access
DOP69 Longitudinal gut microbiome dynamics in relation to disease flares in Inflammatory Bowel Disease, pilot data from the IBD-Tracker study
Journal of Crohn s and Colitis·2024· 1 citedOpen Access
The gut microbiome across the cardiovascular risk spectrum
European Journal of Preventive Cardiology·2023· 26 citedOpen Access
Health-related quality of life is linked to the gut microbiome in kidney transplant recipients
Nature Communications·2023· 17 citedOpen Access
The Gut Microbiome in End-stage Lung Disease and Lung Transplantation
Research Square (Research Square)·2023Open Access
Multiple indicators of gut dysbiosis predict all-cause and cause-specific mortality in solid organ transplant recipients
2023· 2 citedOpen Access
Response to immune checkpoint inhibition is associated with the gut microbiome in advanced KRAS-mutated non-small cell lung cancer
2023· 2 citedOpen Access
Longitudinal gut microbiome changes in immune checkpoint blockade in advanced melanoma
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Rinse K. Weersma(29), Ranko Gaćeša(18), J. Casper Swarte(15), Hermie J. M. Harmsen(13), Arnau Vich Vila(12), Bernadien H. Jansen(12), Laura A. Bolte(11), Jingyuan Fu(10), Alexandra Zhernakova(10), Eleonora A. Festen(10), Elizabeth A. Archie(9), Tim J. Knobbe(8), Stephan J. L. Bakker(8), Jack A. Gilbert(7), José M. Montoya(7), Valerie Collij(7), Laura Grieneisen(7), Mauna Dasari(7), Vincent E. de Meijer(7), Hans Blokzijl(7)